FDA-2026-N-2590
- FDA-2026-N-2590-0001 — Microbiology Devices; Reclassification of Mycobacterium Tuberculosis Cell-Mediated Immunity Tests and Immune Response Enzyme-Linked Immunospot Tests
Back to index · Docket landing · Blog · Why · About · Methodology · RSS